When naloxone-precipitated abstinence occurs in morphine-dependent mice,they exhibit stereotyped jumping. The number of jumps has been used as an abstinence measure and the motivation for them described as ‘escape’. Studies were designed to assess stimulus control and motivation here. Groups of ten dependent and ten saline mice were singly tested in both light and dark conditions in each of five covered cylinders (2-23 in high). Jumps were recorded automatically for 10 min after 10 mg/kg naloxone. At 2 in,which permitted tactile contact with the cover, no jumps occurred in the light or the dark;at 5-11 in, a high incidence of jumping occurred in both the light and the dark; at 23 in,too high for the animal to reach, relatively few jumps occurred in the light but many occurred in the dark. In another study, similar groups were singly tested in the light after naloxone on each of five circular platforms (18 in high, 3—48 in diameter). As the diameter increased, the number of mice jumping to the floor showed a linear decrease concomitant with an increase in latency. This suggests that jumping is controlled by visual and tactile cues; mice do not jump when escape is prevented by a cover which can be touched or a height which cannot be reached; but do jump when such cues are eliminated by intermediate heights or darkness. Latency varies with size of immediate explorable environment.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.